Cargando…
Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Bronchopulmonary Dysplasia
Bronchopulmonary dysplasia (BPD) is the most common chronic respiratory disease in premature infants. However, there is a lack of effective treatment. Mesenchymal stromal cells derived extracellular vesicles (MSC-EVs), as nano- and micron-sized heterogeneous vesicles secreted by MSCs, are the main m...
Autores principales: | Xi, Yufeng, Ju, Rong, Wang, Yujia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013803/ https://www.ncbi.nlm.nih.gov/pubmed/35444971 http://dx.doi.org/10.3389/fped.2022.852034 |
Ejemplares similares
-
Variations in Umbilical Cord Hematopoietic and Mesenchymal Stem Cells With Bronchopulmonary Dysplasia
por: Chaudhury, Sonali, et al.
Publicado: (2019) -
Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension
por: Sharma, Mayank, et al.
Publicado: (2022) -
Safety and Efficacy of Mesenchymal Stem Cells for the Treatment of Evolving and Established Bronchopulmonary Dysplasia: A Systematic Literature Review
por: Giva, Sheiniz, et al.
Publicado: (2022) -
Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020) -
Insight Into the Roles of Non-coding RNA in Bronchopulmonary Dysplasia
por: Xi, Yufeng, et al.
Publicado: (2021)